Search results
Results from the WOW.Com Content Network
Medtronic is the top medical device company in the world for 2018 with an impressive annual revenue nearly $30 billion in 2017. The company experienced a 3% increase in revenue compared with 2016 figures and they reported 'balanced, diversified growth across all groups and regions'.
The FDA said the recall of the device BioZorb Marker, initiated by Hologic in March, was not a product removal, but a correction. The agency also urged patients to report any side effects they ...
depuysynthes .com. DePuy Synthes ( / dəˈpjuː /) is a franchise of orthopaedic and neurosurgery companies. Acquired by Johnson & Johnson in 1998, its companies form part of the Johnson & Johnson Medical Devices group. DePuy develops and markets products under the Codman, DePuy Mitek, DePuy Orthopaedics and DePuy Spine brands.
Levonorgestrel-releasing implant, sold under the brand name Jadelle among others, are devices that release levonorgestrel for birth control. [1] It is one of the most effective forms of birth control with a one-year failure rate around 0.05%. [1] [2] The device is placed under the skin and lasts for up to five years. [3]
(Reuters) - Humacyte said on Friday the U.S. health regulator has extended review of the company's implant that can act as a replacement for an injured or damaged blood vessel, sending its shares ...
Women who have the recalled implants, which have been linked to a cancer called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) are facing a tough decision of what to do next.
This article needs to be updated.The reason given is: the section related to E.U. needs further updates (esp. in sections 3.2 and 4.2.2) as the directives 93/42/EEC on medical devices and 90/385/EEC on active implantable medical devices have been fully repealed on 26 May 2021 by Regulation (EU) no. 2017/745 (MDR); furthermore, Brexit triggers updates in these sections (U.K. developed their own ...
The first lawsuit in the United States against DePuy Orthopaedics was filed on June 15, 2010. [citation needed] Through the multidistrict litigation process, the cases were centralized in different courts depending on the exact implant at issue. The United States Judicial Panel on Multidistrict Litigation (JPML) issued a ruling on December 7 ...